Dalton Einhorn

Principal, Venture Investments

Dalton Einhorn, Principal, Venture Investments, joined Johnson & Johnson Development Corporation in 2010. He is based in New Brunswick, New Jersey.

Prior to joining JJDC, Mr. Einhorn was a Principal with Latterell Venture Partners, a healthcare venture capital firm. His experience also includes 11 years in the pharmaceutical industry. At Hoffmann-La Roche, his roles included Product Manager for Demadex and Rocephin. With Daiichi-Sankyo, Mr. Einhorn held various global pre-launch commercialization leadership roles. Mr. Einhorn also spent four years in the Mergers & Acquisitions group of Credit Suisse.

Mr. Einhorn received an MBA degree from Yale School of Management and a bachelor’s degree from Drew University.